The invention belongs to the technical field of medicine preparations, and discloses preparation of lisinopril sustained-release tablets. The lisinopril sustained-release tablets comprise, by weight, 1%-4% of lisinopril, 54%-66% of matrix materials, 18%-24% of pregelatinized starch, 14.2%-17.6% of microcrystalline cellulose and 0.4%-0.8% of magnesium stearate. The matrix materials are carbomer. The preparation of the lisinopril sustained-release tablets includes smashing the lisinopril according to the weight percentage, filtering the lisinopril via a 100-mesh sieve and then adding the lisinopril into a three-dimensional movable mixer; smashing the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate, filtering the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate via an 80-mesh sieve and then adding the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate into the three-dimensional movable mixer; mixing the lisinopril, the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate with one another by the three-dimensional movable mixer for 30 minutes to obtain mixtures and then directly compressing the mixtures to obtain the lisinopril sustained-release tablets. The preparation has the advantages that the mixtures are directly compressed without coating, so that sustained-release effects can be realized; technologies are simple, and medicine is uniform in release speed.